IBRX R&D Expenses
Immunitybio Inc · R&D Expenses
IBRX R&D Expenses
Latest reported$234.00Mperiod ending
IBRX TTM R&D Expenses ($29.14M → $234.00M)
TTM R&D Expenses
High-resolution chart · PNG
IBRX r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 234,000,000 | |
| 231,546,000 | |
| 215,010,000 | |
| 189,423,000 | |
| 189,134,000 | |
| 185,027,000 | |
| 190,144,000 | |
| 206,455,000 | |
| 204,414,000 | |
| 206,453,000 | |
| 231,866,000 | |
| 233,185,000 | |
| 251,895,000 | |
| 257,365,000 | |
| 229,889,000 | |
| 228,791,000 | |
| 210,956,000 | |
| 206,118,000 | |
| 195,958,000 | |
| 164,461,000 | |
| 150,956,000 | |
| 130,161,000 | |
| 116,407,000 | |
| 109,344,000 | |
| 85,624,000 | |
| 65,750,000 | |
| 50,974,000 | |
| 50,261,000 | |
| 52,768,000 | |
| 54,325,000 | |
| 55,718,000 | |
| 55,259,000 | |
| 51,769,000 | |
| 46,787,000 | |
| 42,044,000 | |
| 39,468,000 | |
| 36,763,000 | |
| 33,446,000 | |
| 29,142,000 | |
| 24,803,000 | |
| 20,389,000 | |
| 15,745,000 |